Cargando…
Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043968/ https://www.ncbi.nlm.nih.gov/pubmed/33135288 http://dx.doi.org/10.1002/alz.12235 |
| _version_ | 1783678404248207360 |
|---|---|
| author | Sabbagh, Marwan Noel Cummings, Jeffrey |
| author_facet | Sabbagh, Marwan Noel Cummings, Jeffrey |
| author_sort | Sabbagh, Marwan Noel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8043968 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80439682021-07-02 Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” Sabbagh, Marwan Noel Cummings, Jeffrey Alzheimers Dement Policy Forum John Wiley and Sons Inc. 2020-11-01 2021-04 /pmc/articles/PMC8043968/ /pubmed/33135288 http://dx.doi.org/10.1002/alz.12235 Text en © 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Policy Forum Sabbagh, Marwan Noel Cummings, Jeffrey Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title | Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title_full | Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title_fullStr | Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title_full_unstemmed | Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title_short | Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019” |
| title_sort | open peer commentary to “failure to demonstrate efficacy of aducanumab: an analysis of the emerge and engage trials as reported by biogen december 2019” |
| topic | Policy Forum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043968/ https://www.ncbi.nlm.nih.gov/pubmed/33135288 http://dx.doi.org/10.1002/alz.12235 |
| work_keys_str_mv | AT sabbaghmarwannoel openpeercommentarytofailuretodemonstrateefficacyofaducanumabananalysisoftheemergeandengagetrialsasreportedbybiogendecember2019 AT cummingsjeffrey openpeercommentarytofailuretodemonstrateefficacyofaducanumabananalysisoftheemergeandengagetrialsasreportedbybiogendecember2019 |